About GTP Technology
GTP Technology is dedicated to serving scientists in multiple industries and offers customized gene-to-proteins services that help them concentrate on their core activities.
Since our creation, we have been involved in the production of many "difficult-to-express and to purify" proteins. As a result, we have acquired a strong expertise in developing both upstream and downstream competitive processes.
Offering a large selection of proprietary and IP-free expression systems, we have no bias towards any particular system and will recommend the system we think is the most appropriate for your project.
We have a similar culture capacity of 50L with each system, allowing us to handle up to hundred gram scale productions in house.
GTP at a glance
• Customized gene-to-protein services
• Over 10 years experience and over 1000 projects completed
• Seasoned scientists
• Production from mg to hundred grams handled in house
• Large selection of bacterial, yeast, insect and mammalian expression systems
- Founding: 2000
- Focus : Service
- Employees: 11-50
- Industry : Biotechnology
Product portfolio of GTP Technology
Here you will find GTP Technology
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous